Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 26 October 2026.
Announcements
185
Total raised
£13.6B
disclosed amounts
The Series C financing comprised £26m in equity led by Anthos Capital and £20m in debt from Mars Capital.
"I am absolutely delighted that less than four months after Railsbank evolved to become Railsr, we have achieved another milestone and closed our Series C, a significant step on our route to profitability."
Scottish Equity Partners led the Series C financing to support international expansion and product development.
The financing round was co-led by Molten Ventures and Gresham House.
"We are delighted at this show of confidence in FocalPoint from new and established investors amidst a challenging market backdrop. Our IP portfolio is strong, this injection of capital will enable us to move faster to meet the demands of several big customers in the US and South East Asia, and to accelerate our IP portfolio growth."
Ringier AG has acquired a stake in LiveScore Group in a transaction that values the sports media and gaming business at £500m.
"This is a hugely significant day for LiveScore Group, as we take a significant step forward following a £50 million strategic investment from Ringier which values our business at £500 million. Ringier, with its Sports Media Group, is the perfect partner as we look to accelerate our expansion into Central and Eastern European territories, given their outstanding expertise, assets and relationships."
The financing round was led by Kairos HQ alongside Schroders Capital and other backers to expand at-home patient care capacity.
"Since Cera’s launch in November 2016 the company has scaled at an unprecedented rate for the sector, benefiting countless lives, and proving the need for technology-powered improvement in healthcare. Receiving such significant financial backing during this period of global economic volatility, is testament to the strength of Cera’s business model, our innovation, and our commitment to revolutionising healthcare. We’re now in pole position to be able to use our unique technology to expand what we do for patients across the world who are in need of care, while relieving pressures on public services."
